Palisade Capital Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,142,782
Closed -$8.7M 384
2025
Q3
$8.7M Sell
2,142,782
-40,361
-2% -$161K 0.24% 119
2025
Q2
$8.51M Sell
2,183,143
-82,055
-4% -$258K 0.24% 116
2025
Q1
$6.55M Buy
2,265,198
+29,774
+1% +$121K 0.19% 140
2024
Q4
$9.19M Sell
2,235,424
-59,155
-3% -$259K 0.25% 115
2024
Q3
$10.3M Sell
2,294,579
-169,470
-7% -$795K 0.27% 110
2024
Q2
$13.5M Buy
2,464,049
+1,138,123
+86% +$7.17M 0.37% 91
2024
Q1
$10.7M Buy
1,325,926
+223,510
+20% +$1.98M 0.28% 107
2023
Q4
$11M Buy
1,102,416
+488,002
+79% +$3.83M 0.29% 108
2023
Q3
$4.91M Buy
614,414
+563
+0.1% +$5.66K 0.14% 157
2023
Q2
$6.75M Buy
+613,851
New +$6.32M 0.18% 145

Other funds holding DH

Palisade Capital Management's DH Position: Q4 2025 in Review

Palisade Capital Management sold out of Definitive Healthcare (DH) in Q4 2025, closing a stake of 2,142,782 shares — an estimated $8.7M sold.

Palisade Capital Management first reported a position in DH in Q2 2023 and held it in 10 quarters. The position peaked at $13.5M in Q2 2024. 122 funds tracked by Wall St. Rank hold DH as of Q4 2025.

  • Palisade Capital Management reported no remaining Definitive Healthcare position as of Q4 2025 after selling out during the quarter.
  • Palisade Capital Management sold 2,142,782 Definitive Healthcare shares in Q4 2025, an estimated $8.7M.
  • Palisade Capital Management first reported a position in Definitive Healthcare in Q2 2023 and held it in 10 quarters.
  • Palisade Capital Management's Definitive Healthcare position peaked at $13.5M in Q2 2024.
  • 122 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2025.

Based on Palisade Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.